ArticleCancer research2014

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

Yu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.